AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 242.71B |
| Enterprise value | 269.17B |
| Trailing P/E | 37.93 |
| Forward P/E | 18.69 |
| PEG ratio (5-yr expected) | 2.02 |
| Price/sales (ttm) | 4.97 |
| Price/book (mrq) | 6.13 |
| Enterprise value/revenue | 5.48 |
| Enterprise value/EBITDA | 19.11 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.15 |
| 52-week change 3 | 8.97% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 80.86 |
| 52-week low 3 | 60.47 |
| 50-day moving average 3 | 78.49 |
| 200-day moving average 3 | 69.79 |
Share statistics
| Avg vol (3-month) 3 | 4.1M |
| Avg vol (10-day) 3 | 4.27M |
| Shares outstanding 5 | 3.1B |
| Implied shares outstanding 6 | 3.11B |
| Float 8 | 1.54B |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 16.88% |
| Shares short (15 Jul 2024) 4 | 5.8M |
| Short ratio (15 Jul 2024) 4 | 1.87 |
| Short % of float (15 Jul 2024) 4 | N/A |
| Short % of shares outstanding (15 Jul 2024) 4 | 0.19% |
| Shares short (prior month 14 Jun 2024) 4 | 7.93M |
Dividends & splits
| Forward annual dividend rate 4 | 1.45 |
| Forward annual dividend yield 4 | 1.86% |
| Trailing annual dividend rate 3 | 2.97 |
| Trailing annual dividend yield 3 | 3.78% |
| 5-year average dividend yield 4 | 2.44 |
| Payout ratio 4 | 70.39% |
| Dividend date 3 | 25 Mar 2024 |
| Ex-dividend date 4 | 22 Feb 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 27 Jul 2015 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 30 Jun 2024 |
Profitability
| Profit margin | 13.11% |
| Operating margin (ttm) | 22.42% |
Management effectiveness
| Return on assets (ttm) | 7.68% |
| Return on equity (ttm) | 16.74% |
Income statement
| Revenue (ttm) | 49.13B |
| Revenue per share (ttm) | 2.63 |
| Quarterly revenue growth (yoy) | 13.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 16.97B |
| Net income avi to common (ttm) | 6.44B |
| Diluted EPS (ttm) | 2.06 |
| Quarterly earnings growth (yoy) | 6.00% |
Balance sheet
| Total cash (mrq) | 7.08B |
| Total cash per share (mrq) | 4.57 |
| Total debt (mrq) | 33.65B |
| Total debt/equity (mrq) | 84.97% |
| Current ratio (mrq) | 0.89 |
| Book value per share (mrq) | 25.49 |
Cash flow statement
| Operating cash flow (ttm) | 11.06B |
| Levered free cash flow (ttm) | 9.82B |
© 2024 Yahoo. All rights reserved.